1. Oncological safety of nipple-sparing mastectomy in young patients with breast cancer compared with conventional mastectomy
- Author
-
Changyuan Wei, Qinghong Qin, Junyang Mo, Shuting Qin, Bin Lian, Zhen Huang, Qixing Tan, Jiapeng Huang, Yaqiang Zhuang, Cao Yiming, and Qinguo Mo
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,030230 surgery ,03 medical and health sciences ,oncological safety ,0302 clinical medicine ,Breast cancer ,breast cancer ,Internal medicine ,medicine ,Stage (cooking) ,Lymph node ,young patient ,nipple-sparing mastectomy ,business.industry ,Cancer ,Articles ,Progesterone Receptor Status ,medicine.disease ,early stage ,Molecular medicine ,medicine.anatomical_structure ,Estrogen ,030220 oncology & carcinogenesis ,prognosis ,business ,Mastectomy - Abstract
Although nipple-sparing mastectomy (NSM) is being used more frequently, the oncological safety of NSM remains unclear, particularly in young patients (0.05). Following adjustment for clinical stage, the LR and DFS rates between the two groups exhibited no significant differences. Analysis of the prognostic factors demonstrated that clinical stage, lymph node status, estrogen and progesterone receptor status and human epidermal growth factor receptor 2 status were associated with DFS (P
- Published
- 2018